CHARACTERIZATION OF B7H6, AN ENDOGENOUS LIGAND FOR THE NK CELL ACTIVATING RECEPTOR NKP30, REVEALS THE IDENTITY OF TWO DIFFERENT SOLUBLE ISOFORMS DURING NORMAL HUMAN PREGNANCY
B7H6, an endogenous ligand expressed on tumor cell surfaces, triggers NKp30-mediated activation of human NK cells. In contrast, the release of soluble B7H6 has been proposed as a novel mechanism by which tumors might evade NK cell-mediatedrecognition. Since NK cells are critical for the maintenance...
| Autores: | , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2018 |
| País: | México |
| Institución: | Universidad Autónoma de Nayarit |
| Repositorio: | Repositorio Institucional Aramara de la UAN |
| Idioma: | inglés |
| OAI Identifier: | oai:dspace.uan.mx:123456789/1094 |
| Acceso en línea: | http://dx.doi.org/10.1016/j.imbio.2017.10.012 http://dspace.uan.mx:8080/jspui/handle/123456789/1094 |
| Access Level: | acceso abierto |
| Palabra clave: | PregnancyB7H6NKp30NK cells EmbarazoB7H6NKp30NK células EMBRIOLOGÍA HUMANA [241006] |
| Sumario: | B7H6, an endogenous ligand expressed on tumor cell surfaces, triggers NKp30-mediated activation of human NK cells. In contrast, the release of soluble B7H6 has been proposed as a novel mechanism by which tumors might evade NK cell-mediatedrecognition. Since NK cells are critical for the maintenance of early pregnancy, it is not illogical that soluble B7H6 might also be an important factor in directing NK cell activity during normal pregnancy. Thus, this study was focused on the characterization of soluble B7H6 during the development of normal pregnancy. Serum samples were obtained from healthy pregnant women who were experiencing their second pregnancies (n = 36). Additionally, 17 of these pregnant participants were longitudinally studied for the presence of B7H6 during their second and third trimesters. Age-matched healthy non-pregnant women served as controls (n = 30). The presence of soluble B7H6 was revealed by Western blotting. A further characterization was performed using an immunoproteomic approach b sed on 2DE-Western blotting combined with MALDI-MS. The results show that sera from all pregnant women were characterized by the presence of two novel isoforms of B7H6, both with lower MW than the reported of 51 kDa. These isoforms were either a heavy (∼37 kDa) or a light isoform (∼30 kDa) and were mutually exclusive. N-glycosylation did not completely explain the different molecular weights exhibited by the two isoforms, as was demonstrated by enzymatic deglycosylation with PNGase F. The confirmation of the identity and molecular mass of each isoform indicates that B7H6, while maintaining the C- and N-termini, is most likely released during pregnancy by a mechanism distinct from proteolytic cleavage. We found that both isoforms, but mainly the heavier B7H6, were released via exosomes; and that the lighter isoform was also released in an exosome-free manner that was not observed in the heavy isoform samples. In conclusion, we find that soluble B7H6 is constitutively expressed during pregnancy and that, moreover, the soluble B7H6 is present in two new isoforms, which are released by exosomal and exosome-free mechanisms. |
|---|